(Reuters) -Virtual chronic care provider Omada Health is targeting a valuation of about $1.1 billion in its initial public offering in the United States, signaling a comeback for capital markets after several months of slowdown in listings.
The company said on Thursday it would sell 7.9 million shares in a range of $18 to $20 per share, potentially fetching up to $158 million if priced at the upper limit.
While U.S. President Donald Trump’s tariff whiplash has roiled markets and cast a shadow on new listings, companies in sectors perceived as less sensitive to economic headwinds are pushing ahead with their initial public offerings.
The San Francisco, California-based company, last raised $192 million in a Series E funding round in 2022.
Omada has applied to list its common stock on the Nasdaq under the symbol "OMDA".
J.P.Morgan, Goldman Sachs, Morgan Stanley and Barclays are among the underwriters for Omada’s offering.